6368:TSEOrgano Corp. Analysis

Organo Corp's stock trades at 16,815 JPY, sitting comfortably above its 20‑day SMA of 16,884 and 50‑day SMA of 15,761, indicating a short‑term bullish bias. The 200‑day SMA of 13,804 also lies well below the price, confirming a longer‑term uptrend. Momentum is neutral, with the 14‑day RSI at 52, suggesting no immediate overbought or oversold pressure. However, the MACD histogram is negative (‑172) and the MACD signal line sits above the MACD line, flagging bearish momentum in the near term. Technical support sits at 15,560 JPY, while resistance caps the 52‑week high at 20,145 JPY, giving the stock roughly 21% upside to the consensus target of 20,450 JPY. Volatility is elevated at 53% over the past 30 days and beta of 1.16, implying the share moves more than the market and may swing sharply. On the fundamentals side, revenue grew 4.9% YoY, margins are solid (gross 36.6%, operating 23.1%, profit 16.0%) and cash flow is healthy, with free cash flow of 6.1 bn JPY.
The company trades at a forward PE of 37 versus an industry average of 29.7, and a price‑to‑book of 5.4, suggesting the market is pricing in premium growth expectations. The dividend yield is modest at 0.27% with a payout ratio of 32%, which appears sustainable given the robust cash generation. Analysts (2) rate the stock as a “strong buy” with a mean target of 20,450 JPY, implying about 22% upside. The balance sheet shows a debt‑to‑equity of 24, but cash on hand nearly matches total debt, mitigating solvency concerns. The “Extreme Greed” sentiment on the fear‑greed index (91.6) reflects strong market appetite, yet the high volatility and sector exposure to environmental regulation warrant caution. Overall, the blend of solid earnings, dividend stability, and upside potential supports a medium‑term buying case, while short‑term technical mixed signals advise a wait‑and‑see stance. Investors should monitor MACD convergence and any regulatory developments that could impact the pollution‑treatment segment.